Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Other financing activities: 2019-2024

Historic Other financing activities for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$6.7 million.

  • MDxHealth's Other financing activities fell 30.33% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.1 million, marking a year-over-year decrease of 179.07%. This contributed to the annual value of -$6.7 million for FY2024, which is 285.65% down from last year.
  • Per MDxHealth's latest filing, its Other financing activities stood at -$6.7 million for FY2024, which was down 285.65% from $3.6 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Other financing activities ranged from a high of $3.6 million in FY2023 and a low of -$6.7 million during FY2024.
  • For the 3-year period, MDxHealth's Other financing activities averaged around -$560,000, with its median value being $1.4 million (2022).
  • Its Other financing activities has fluctuated over the past 5 years, first soared by 194.49% in 2021, then plummeted by 285.65% in 2024.
  • MRY analysis of 5 years shows MDxHealth's Other financing activities stood at -$1.1 million in 2020, then skyrocketed by 194.49% to $1.0 million in 2021, then skyrocketed by 39.66% to $1.4 million in 2022, then surged by 155.67% to $3.6 million in 2023, then crashed by 285.65% to -$6.7 million in 2024.
  • Its Other financing activities was -$6.7 million in FY2024, compared to $3.6 million in FY2023 and $1.4 million in FY2022.